NCT07489079 · NYU Langone Health
PlayReadVIP in Family Child Care
What this study is about
This study uses a mixed-methods, single-group pretest-posttest design to evaluate (1) implementation outcomes (acceptability, adoption, fidelity) and (2) preliminary changes associated with delivery of the adapted PlayReadVIP intervention in Family Care Center (FCC) settings.
View original scientific description
This study uses a mixed-methods, single-group pretest-posttest design to evaluate (1) implementation outcomes (acceptability, adoption, fidelity) and (2) preliminary changes associated with delivery of the adapted PlayReadVIP intervention in Family Care Center (FCC) settings.
Interventions
BEHAVIORAL
PlayReadVIP
PlayReadVIP (formerly the Video Interaction Project) is an intervention that uses a strengths-based reflective-practice model to coach parents on positive parenting interactions with their children during book reading and play.
Primary outcome measures
Provider Self-Efficacy
Time frame: Pre-Intervention (Baseline), Post-Intervention Session (Day 1 up to Day 30, approximately)
Provider self-efficacy is measured using the Beliefs About Parent Support for Early Literacy Scale (BPSES). The BPSES consists of items assessing providers' confidence in managing children's behavior and supporting children's development. Items are rated on a 5-point Likert scale ranging from Strongly disagree to Strongly agree. The total score is calculated by summing all five items, and ranges from 5 to 25, with higher scores indicating greater provider self-efficacy.
Provider Perceptions of Children's Literacy Practices
Time frame: Pre-Intervention (Baseline), Post-Intervention Session (Day 1 up to Day 30, approximately)
The Provider Perception survey was developed by the NYULH PlayReadVIP research team and includes frequency-based items assessing how often children in the provider's care engage in literacy-related behaviors, social interaction, communication, sustained attention during reading, and challenging behaviors. Each item is rated on a 10-point Likert scale from 0-9. The total score is the sum of responses and ranges from 0-72, with higher scores indicating greater frequency of the specified behaviors.
Cognitive Stimulation in the Caregiving Environment
Time frame: Pre-Intervention (Baseline), Post-Intervention Session (Day 1 up to Day 30, approximately)
The StimQ-2 is a standardized, validated caregiver-report measure designed to assess the quality and frequency of cognitive stimulation activities provided to children in early childcare settings. The instrument includes 5-point Likert scale from 0-5 across multiple domains, including shared reading practices, caregiver teaching activities, verbal responsiveness, and availability of developmentally appropriate learning materials. The highest total StimQ Score is 39 and the lowest is 0. Higher scores indicate greater provision of cognitive stimulation within the caregiving environment.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- 18 years of age or older
- Family childcare provider or assistant in MARC Network who cares for children who are 0-5 years of age
- English or Spanish-speaking
Exclusion criteria
- Less than 18 years old
- Does not speak English or Spanish
Where
- New York, New York
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 1, 2026 · Source of record for eligibility and locations